H
Hirofumi Ogawa
Publications - 45
Citations - 587
Hirofumi Ogawa is an academic researcher. The author has contributed to research in topics: Chemoradiotherapy & Induction chemotherapy. The author has an hindex of 13, co-authored 40 publications receiving 379 citations.
Papers
More filters
Journal ArticleDOI
Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer
Tomoya Yokota,Ken Kato,Yasuo Hamamoto,Yasuhiro Tsubosa,Hirofumi Ogawa,Yoshinori Ito,Hiroki Hara,Takashi Ura,Takashi Kojima,Keisho Chin,Shuichi Hironaka,Takayuki Kii,Yasushi Kojima,Yasunori Akutsu,Hisayuki Matsushita,Kentaro Kawakami,Keita Mori,Yushi Nagai,Chika Asami,Yuko Kitagawa +19 more
TL;DR: Chemoselection with DCF-ICT followed by CS as a multidisciplinary treatment strategy showed promising signs of tolerability and efficacy in patients with locally advanced unresectable SCC of the oesophagus.
Journal ArticleDOI
Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE)
Mitsumi Terada,Hiroki Hara,Hiroyuki Daiko,Junki Mizusawa,Tomohiro Kadota,Keisuke Hori,Hirofumi Ogawa,Takashi Ogata,Katsuyuki Sakanaka,Takeshi Sakamoto,Ken Kato,Yuko Kitagawa +11 more
TL;DR: The purpose of this study is to confirm the superiority of induction chemotherapy with docetaxel plus cisplatin and 5-fluorouracil followed by conversion surgery or definitiveCRT over definitive CRT alone for overall survival (OS) in patients with locally advanced unresectable squamous-cell carcinoma of thoracic esophagus.
Journal ArticleDOI
Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
Takeshi Kawakami,Takahiro Tsushima,Katsuhiro Omae,Hirofumi Ogawa,Hiromichi Shirasu,Yosuke Kito,Yukio Yoshida,Satoshi Hamauchi,Akiko Todaka,Nozomu Machida,Tomoya Yokota,Kentaro Yamazaki,Akira Fukutomi,Yusuke Onozawa,Hirofumi Yasui +14 more
TL;DR: This study demonstrated that total circumferential lesion and CRP ≥1.00 mg/dL are risk factors for esophageal fistula in T4b thoracic ESCC treated with dCRT.
Journal ArticleDOI
Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.
Sadayuki Kawai,Tomoya Yokota,Yusuke Onozawa,Satoshi Hamauchi,Akira Fukutomi,Hirofumi Ogawa,Tsuyoshi Onoe,Tetsuro Onitsuka,Takashi Yurikusa,Akiko Todaka,Takahiro Tsushima,Yukio Yoshida,Yosuke Kito,Keita Mori,Hirofumi Yasui +14 more
TL;DR: The cause-specific incidence and clinical risk factors for aspiration pneumonia after definitive CRT or BRT were investigated in patients with locally advanced HNC and a predictive model was constructed that may be useful for identifying patients at high risk of aspiration pneumonia.
Journal ArticleDOI
Comparison of curative surgery and definitive chemoradiotherapy as initial treatment for patients with cervical esophageal cancer
Katsushi Takebayashi,Yasuhiro Tsubosa,Satoru Matsuda,Keisuke Kawamorita,Masahiro Niihara,Takahiro Tsushima,Tomoya Yokota,Hiroshi Sato,Yusuke Onozawa,Hirofumi Ogawa,Tomoyuki Kamijo,Tetsuro Onitsuka,Masahiro Nakagawa,Hirofumi Yasui +13 more
TL;DR: Chemoradiotherapy should be selected as the initial larynx-preserving treatment for patients with cervical esophageal cancer although chemoradi therapy non-responders require additional treatment, including salvage surgery.